TERRI HASKINS: Open Payments
NPI 1689632580 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,456 in 70 payments from 14 companies in 2025. Trend: 2023 $247 · 2024 $3,238 · 2025 $18,456
Honoraria: $12,600Travel & lodging: $4,093Food & beverage: $1,764
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 45 | $17,983 |
| Teva Pharmaceuticals USA, Inc. | 5 | $96 |
| PFIZER INC. | 5 | $87 |
| Alkermes, Inc. | 4 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Lundbeck LLC | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Indivior Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: BRIXADI, ELIQUIS, AUSTEDO XR, COBENFY, HETLIOZ, ARISTADA, VIVITROL, UZEDY.
Industry payments across NY — which companies pay providers there.
